Thus, MKK3 can play a dual role in cancer: one as a lost tumor suppressor acting through the p38-pathway [81, 82], and another as an oncogene through upregulation of different oncogenic programs, such as the MYC transcription. Here, MAP2K3 is linked to neoplasm.